FRAUD FILES
"Diovan data-manipulation scandal touches Novartis in Japan"   
Heart Jul 19  
http://www.theheart.org/article/1561843.do 
" . . .  Kyoto Prefectural University announced that the Kyoto Heart Study data were "very likely" fabricated, according to AFP. "Incomplete" patient data were used in the study, which concluded the blood-pressure drug could also reduce other cardiovascular end points via mechanisms unrelated to blood-pressure lowering. Had "complete patient records" been used, the study would have reached "a different conclusion," the university concluded."